EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ·Healthcare·Biotechnology
$13.45
-1.10%
Mkt Cap $1.15B
Next Earnings
In 8 daysWed, May 6, 2026
EPS Estimate
-$0.79
6 analysts
Revenue Estimate
$352.83K
Last quarter: missed by -3.85% on EPS, -37.65% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$1.15B
P/E
—
Fwd P/E
—
P/S
36.81
Rev TTM
—
EPS TTM
-$3.16